First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer

Published:2021-07-16 Issue: Volume: Page:jnumed.121.261926
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Niemeijer Anna-Larissa Nadia,Oprea Lager Daniela E,Huisman Marc C,Hoekstra Otto S,Boellaard Ronald,van de Veen Berlinda,Bahce Idris,Vugts Danielle J,van Dongen Guus AMS,Thunnissen Erik,Smit Egbert,de Langen Adrianus J.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of 18F-fluorodeoxyglucose positron emission tomography-based radiomics in non-small cell lung cancer;Tzu Chi Medical Journal;2024-09-03

2. DCE-CT parameters as new functional imaging biomarkers at baseline and during immune checkpoint inhibitor therapy in patients with lung cancer – a feasibility study;Cancer Imaging;2024-08-13

3. Illuminating immunotherapy response via precision T cell-targeted PET imaging;Frontiers in Medicine;2024-07-22

4. Meta-Analysis of the Efficacy and Safety of Pembrolizumab in the Treatment of Advanced Gastric Cancer and Gastroesophageal Junction Cancer;Chemotherapy;2024-07-17

5. Navigating the landscape of PD-1/PD-L1 imaging tracers: from challenges to opportunities;Frontiers in Medicine;2024-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP